Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Amortization of Deferred Charges: 2022-2024

Historic Amortization of Deferred Charges for Orchestra BioMed Holdings (OBIO) over the last 3 years, with Dec 2024 value amounting to $31,000.

  • Orchestra BioMed Holdings' Amortization of Deferred Charges was N/A to $59,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $154,000, marking a year-over-year change of. This contributed to the annual value of $31,000 for FY2024, which is 72.32% down from last year.
  • As of FY2024, Orchestra BioMed Holdings' Amortization of Deferred Charges stood at $31,000, which was down 72.32% from $112,000 recorded in FY2023.
  • In the past 5 years, Orchestra BioMed Holdings' Amortization of Deferred Charges registered a high of $163,000 during FY2022, and its lowest value of $31,000 during FY2024.
  • Its 3-year average for Amortization of Deferred Charges is $102,000, with a median of $112,000 in 2023.
  • Data for Orchestra BioMed Holdings' Amortization of Deferred Charges shows a maximum YoY tumbled of 72.32% (in 2024) over the last 5 years.
  • Yearly analysis of 3 years shows Orchestra BioMed Holdings' Amortization of Deferred Charges stood at $163,000 in 2022, then crashed by 31.29% to $112,000 in 2023, then crashed by 72.32% to $31,000 in 2024.